ArticleBulletin of the World Health Organization2026
Laboratory tools from the Fleming Fund antimicrobial resistance surveillance programme.
Article in Bulletin of the World Health Organization, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Problem: Current laboratory assessment tools aimed at improving bacteriology and testing for antimicrobial resistance focus on quality of laboratory services. No guidance exists for establishing bacteriology services necessary for diagnosis and surveillance of antimicrobial resistance in low- and middle-income countries. Approach: Comprehensive laboratory needs assessment tools and procurement catalogues were developed, piloted and used by the Fleming Fund programme. These tools were designed to support the strengthening of bacteriology testing capacity within national antimicrobial resistance surveillance systems receiving Fleming Fund support. Setting: The tools were used in reference laboratories and surveillance sites for antimicrobial resistance in 24 countries in the African, South-East Asia and Western Pacific regions, comprising 341 clinical, veterinary, aquaculture, food safety and environmental laboratories. Relevant changes: The needs assessment tool provides a structured framework for laboratory renovation and installation of bacteriology testing equipment. The procurement catalogues list reagents and consumables for antimicrobial resistance surveillance of priority pathogens in humans in the World Health Organization Global Antimicrobial Resistance and Use Surveillance System and selected bacteria in terrestrial and aquatic food-producing animals. Combined with training and capacity-building initiatives supported through other Fleming Fund investments, these efforts have substantially enhanced diagnostic capacity for bacterial infections and antimicrobial resistance surveillance in the laboratories. Lessons learnt: These tools were instrumental in identifying gaps to enhance bacteriology laboratory capacity and capabilities and became an essential resource for procurement, tracking supplies and asset management. The tools are adaptable and can strengthen laboratory capacity in settings and health programmes beyond bacteriology and antimicrobial resistance surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.